Who Owns CytoMed Therapeutics Limited (GDTC)?Hedge Fund & Institutional Holders

$1.05-0.01 (-0.94%)HealthcareNASDAQ

Institutional Holders

5

as of Q4 2025

Total Institutional Value

$10.0B

% of Float Held

QoQ Change in Holders

+4 / -1

Price History

$0.81$1.48$2.15$2.83$3.50Sep 24Jun 25Mar 26

GDTC — Biggest New Institutional Buyers This Quarter

FundActionShares AddedValue Added
SUSQUEHANNA INTERNATIONAL GROUP, LLPNew Position+30K+$0
TWO SIGMA SECURITIES, LLCNew Position+12K+$0
OSAIC HOLDINGS, INC.New Position+21+$0
StoneX Group Inc.New Position+10K+$0

GDTC — Institutions Reducing or Closing Positions

FundActionShares SoldValue Sold
UBS Group AGDecreased-12K-$25.4M
Wealthspire Advisors, LLCClosed Position-5K-$9.6M

Top Institutional Holders(Q4 2025)

#FundSharesValue% of PortfolioType
1UBS Group AG1,065$1.0M0.00%Share
2StoneX Group Inc.10,356$00.00%Share
3TWO SIGMA SECURITIES, LLC11,857$00.00%Share
4OSAIC HOLDINGS, INC.21$00.00%Share
5SUSQUEHANNA INTERNATIONAL GROUP, LLP29,829$00.00%Share

GDTC Institutional Ownership History

QuarterHoldersTotal ValueChange
Q4 20255$1.0M+3
Q3 20252$36.1M-1
Q2 20253$98.5M+1
Q1 20252$70.3M+0
Q4 20242$34.3M+0
Q3 20242$96K+1
Q2 20241$0-1
Q1 20242$28K

Similar Stocks by Institutional Ownership

As of Q4 2025, 5 institutional investors hold GDTC (CytoMed Therapeutics Limited). The largest holder is UBS Group AG with $1.0M in shares. This quarter, 4 institutions opened new positions and 1 closed their positions.

Frequently Asked Questions

How many hedge funds own GDTC?

As of Q4 2025, 5 institutional investors report holding GDTC (CytoMed Therapeutics Limited) in their 13F filings.

Who is the largest institutional holder of GDTC?

The largest institutional holder of GDTC is UBS Group AG with $1.0M in shares.

Is institutional ownership of GDTC increasing or decreasing?

This quarter, 4 institutions opened new positions in GDTC and 1 closed their positions.